The LIM protein, LIMD1, regulates AP-1 activation through an interaction with TRAF6 to influence osteoclast development

被引:44
作者
Feng, Yunfeng
Zhao, Haibo
Luderer, Hilary F.
Epple, Holly
Faccio, Roberta
Ross, F. Patrick
Teitelbaum, Steven L.
Longmore, Gregory D.
机构
[1] Washington Univ, Sch Med, Div Hematol, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Dept Cell Biol, St Louis, MO 63110 USA
[3] Washington Univ, Dept Pathol, St Louis, MO 63110 USA
[4] Washington Univ, Dept Orthoped Surg, St Louis, MO 63110 USA
关键词
D O I
10.1074/jbc.M607399200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Increasingly a number of proteins important in the regulation of bone osteoclast development have been shown primarily influence osteoclastogenesis under conditions of physiologic or pathologic stress. Why basal osteoclastogenesis is normal and how these proteins regulate stress osteoclastogenic responses, as opposed to basal osteoclastogenesis, is unclear. LIM proteins of the Ajuba/Zyxin family localize to cellular sites of cell adhesion where they contribute to the regulation of cell adhesion and migration, translocate into the nucleus where they can affect cell fate, but are also found in the cytoplasm where their function is largely unknown. We show that one member of this LIM protein family, Limd1, is uniquely up-regulated during osteoclast differentiation and interacts with Traf6, a critical cytosolic regulator of RANK-L-regulated osteoclast development. Limd1 positively affects the capacity of Traf6 to activate AP-1, and Limd1(-/-) osteoclast precursor cells are defective in the activation of AP-1 and thus induction of NFAT2. Limd1(-/-) mice, although having normal basal bone osteoclast numbers and bone density, are resistant to physiological and pathologic osteoclastogenic stimuli. These results implicate Limd1 as a potentially important regulator of osteoclast development under conditions of stress.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 48 条
[1]
Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adaptor proteins that regulates life and death [J].
Arch, RH ;
Gedrich, RW ;
Thompson, CB .
GENES & DEVELOPMENT, 1998, 12 (18) :2821-2830
[2]
NF-κB-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis [J].
Aya, K ;
Alhawagri, M ;
Hagen-Stapleton, A ;
Kitaura, H ;
Kanagawa, O ;
Novack, DV .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (07) :1848-1854
[3]
FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner [J].
Bai, ST ;
Kitaura, H ;
Zhao, HB ;
Chen, J ;
Müller, JM ;
Schüle, R ;
Darnay, B ;
Novack, DV ;
Ross, FP ;
Teitelbaum, SL .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2742-2751
[4]
Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain [J].
Baud, V ;
Liu, ZG ;
Bennett, B ;
Suzuki, N ;
Xia, Y ;
Karin, M .
GENES & DEVELOPMENT, 1999, 13 (10) :1297-1308
[5]
Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[6]
Tumor necrosis factor receptor-associated factors (TRAFs) [J].
Bradley, JR ;
Pober, JS .
ONCOGENE, 2001, 20 (44) :6482-6491
[7]
Osteoclast differentiation is impaired in the absence of inhibitor of κB kinase α [J].
Chaisson, ML ;
Branstetter, DG ;
Derry, JM ;
Armstrong, AP ;
Tometsko, ME ;
Takeda, K ;
Akira, S ;
Dougall, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (52) :54841-54848
[8]
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms [J].
David, JP ;
Sabapathy, K ;
Hoffmann, O ;
Idarraga, MH ;
Wagner, EF .
JOURNAL OF CELL SCIENCE, 2002, 115 (22) :4317-4325
[9]
Dunne A, 2003, SCI STKE, V2003, pre3, DOI DOI 10.1126/STKE.2003.171.RE3
[10]
The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis [J].
Durán, A ;
Serrano, M ;
Leitges, M ;
Flores, JM ;
Picard, S ;
Brown, JP ;
Moscat, J ;
Diaz-Meco, MT .
DEVELOPMENTAL CELL, 2004, 6 (02) :303-309